Patent Number: 8,574,585

Title: KDR peptides and vaccines comprising the same

Abstract: The present invention provides nonapeptides selected from peptides comprising the amino acid sequence of SEQ ID NO:2, 3, 5, 8, 11, or 12; nonapeptides or decapeptides selected from peptides comprising the amino acid sequence of SEQ ID NO:29, 30, 33, 34, 40, or 46; and peptides with cytotoxic T cell inducibility, in which one, two, or several amino acids are substituted or added to the above-mentioned amino acid sequences, as well as pharmaceuticals for treating or preventing tumors, where the pharmaceuticals comprise these peptides. The peptides of this invention can be used as vaccines.

Inventors: Tahara; Hideaki (Meguro-ku, JP), Wada; Satoshi (Meguro-ku, JP), Tsunoda; Takuya (Minato-ku, JP)

Assignee: Oncotherapy Science, Inc.

International Classification: A61K 38/04 (20060101); C07K 7/06 (20060101); C07K 14/71 (20060101)

Expiration Date: 1/05/12017